Expert Opinion on Biological Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 18, 2023 Category: Drugs & Pharmacology Authors: A ChiricozziSM FerrucciL Di NardoN GoriA BalatoM OrtoncelliM MaurelliM GalluzzoM Munera CamposT SeremetG CaldarolaC De SimoneE IppolitiT TorresS GkalpakiotisC ConradJM CarrascosaL BianchiG ArgenzianoS RiberoG GirolomoniAV MarzanoK Perisa Dermatologia, Dip Source Type: research
An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 15, 2023 Category: Drugs & Pharmacology Authors: Alexandria MaticNouf AlfaidiVera BrilThe Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada Source Type: research
Intravenous immunoglobulin as a potential treatment for long COVID
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 15, 2023 Category: Drugs & Pharmacology Authors: Matthew W. McCarthyDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA Source Type: research
Integrating CAR-T cell therapy into the management of DLBCL: what we are learning
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 11, 2023 Category: Drugs & Pharmacology Authors: Massimo MartinoFilippo Antonio CanaleGaetana PortoChiara VerduciGiovanna UtanoGiorgia PolicastroJessyca German òCaterina AlatiLudovica SantoroLucrezia ImbalzanoMartina Piteaa Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hem Source Type: research
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 11, 2023 Category: Drugs & Pharmacology Authors: Reyna KV LimMatthew BuschmanAlisher KhasanovArthur LedesmaJohn ChenThanhtruc NguyenJoanna GuoLingna LiJonathan HuangJin NiuLisa KerwinRengang WangYurong GuoTong ZhuGunnar KaufmannYanliang ZhangHeyou ZhouHenry JiYanwen FuAntibody Discovery & Technology, S Source Type: research
Adjuvant immunotherapy for locally advanced renal cell carcinoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 9, 2023 Category: Drugs & Pharmacology Authors: Michail AlevizakosDavid McDermotta Department of Hematology/Medical Oncology, Riverside Cancer Specialists of Tidewater, Chesapeake, VA, USAb Hematology/Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA Source Type: research
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - December 4, 2023 Category: Drugs & Pharmacology Authors: Hendrik WesselsOliver von RichterMaria VelinovaJosef H öflerPaul ChamberlainArno KrommingaDirk LehnickKarsten Rotha Polpharma Biologics S.A, Gdansk, Polandb Hexal AG (A Sandoz company), Holzkirchen, Germanyc Early Development Services, ICON, Groningen, T Source Type: research
Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 27, 2023 Category: Drugs & Pharmacology Authors: Nik KamperidisMoulesh ShahSophie YoungEvgeniy GalimovShruti SweeneyNaila Arebia Department of Gastroenterology, St Marks Hospital, London, UKb Imperial College Health Partners, London, UKc Janssen Cilag Limited, High Wycombe, UK Source Type: research
Non-traditional approaches for control of antibiotic resistance
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 26, 2023 Category: Drugs & Pharmacology Authors: Siddharth C UmarjeSanjiban K Banerjeea Department of Proteomics, AbGenics Life Sciences Pvt. Ltd., Pune, Indiab AbGenics Life Sciences Pvt. Ltd., Pune, India Source Type: research
The history of Crohn ’s perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 22, 2023 Category: Drugs & Pharmacology Authors: Damian Garc ía-OlmoMariano Garcia-Arranza New Therapies Laboratory, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD), Madrid, Spainb Department of Surgery, Fundación Jiménez Díaz University Hospital, Madrid, Spain Source Type: research
Biological therapy in polymyalgia rheumatica
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 21, 2023 Category: Drugs & Pharmacology Authors: Daniel Wendlinga Rheumatology, CHU (University Teaching Hospital), Besan çon, Franceb EA4266 EPILAB, Université de Franche-Comté, Besançon, France Source Type: research
The endosomal-lysosomal system in ADC design and cancer therapy
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 18, 2023 Category: Drugs & Pharmacology Authors: Jeffrey V. LeytonSchool of Pharmaceutical Sciences and Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada Source Type: research
The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 16, 2023 Category: Drugs & Pharmacology Authors: Taner Co şkunerŞengül ÇağlayanÖzlem AkgünRüya TorunEmine Nur Sunar Yaylaİ̇lknur BagrulGülşah KılbaşGülçin Otar YenerHülya KöseKübra ÖztürkÖzge BabaMustafa ÇakanFerhat DemirHafize Emine SönmezMukaddes KalyoncuSara Nşebnem KılıçS Source Type: research
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 14, 2023 Category: Drugs & Pharmacology Authors: Tro SekayanDana H. SimmonsAnnette von Drygalskia Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USAb Capitol Scientific, Washington DC, USA Source Type: research
Antibody drug conjugates for glioblastoma: current progress towards clinical use
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 13, 2023 Category: Drugs & Pharmacology Authors: Hui K GanSagun ParakhLaura D OsellameLawrence CherAnthony UccelliniUmbreen HafeezSiddharth MenonAndrew M Scotta Cancer Therapies and Biology Group, Centre of Research Excellence in Brain Tumours, Olivia Newton-John Cancer Wellness and Research Centre, Aus Source Type: research
